Haploidentical stem cell transplantation using PTCY for children with acute leukemia Group Paediatric Diseases Working Party (PDWP) Principal investigator Annalisa Ruggeri
Use of eculizumab to treat thrombotic microangiopathy associated with haematopoietic stem cell transplantation - a retrospective study on behalf of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation Diseases Group Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator Peter Svec
Pregnancy rates and Pregnancy outcomes after hematopoietic stem cell transplantation in childhood Diseases Group Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator Tamara Diesch-Furlanetto
Retrospective analysis on the outcome of autologous and allogeneic stem cell transplantation in children and adolescents with non-anaplastic peripheral T-cell lymphoma Group Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator Olga Moser
Haematopoietic stem cell transplantation in children and adolescents with non hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation Group Paediatric Diseases Working Party (PDWP) Type of transplant Principal investigator Laura Alonso
Allogeneic stem cell transplantation for refractory AML: a comparison between sequential or standard myeloablative conditioning regimen (a retrospective study). Group Paediatric Diseases Working Party (PDWP) Principal investigator Audrey Grain
Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation Diseases Group Paediatric Diseases Working Party (PDWP) Other society Principal investigator Fanette Bernard
Outcome after allogeneic SCT for MLL-PTD AML Group Acute Leukemia Working Party (ALWP) Principal investigator Marta Pratcorona
Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) Group Acute Leukemia Working Party (ALWP) Principal investigator Sabine BLUM , Yves Chalandon
Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL. Group Acute Leukemia Working Party (ALWP) Principal investigator Klaus HIRSCHBUEHL
HSCT experience in patients with Interferon gamma receptor deficiencies Diseases Group Inborn Errors Working Party (IEWP) Type of transplant Principal investigator Peter Olbrich
Outcomes of patients treated with Ibrutinib post autologous stem cell transplant for mantle cell lymphoma. Group Lymphoma Working Party (LWP) Principal investigator Steve Robinson / Claire Burney